Russian Medical Development: News

Ironically the fact that a huge amount of russians stubbornly oppose whatever their country produces(they view everythingthe west produces as inherently superior) or subscribe to antivaxxer alternative medicine has reduced demand and allowed those who want to get vaccinated the ability to do so.

Does anyone know if Russia is offering the Sputnik vaccine to citizens abroad in Russian embassies?

Walther von Oldenburg wrote:Can western medical research improve upon and exceed the efficiacy of Western medical research?>

This is already a case to a degree with Sputnik 5.

MOSCOW (Reuters) - A Russian trial testing the effectiveness of revaccination with the Sputnik V shot to protect against new mutations of the coronavirus is producing strong results, researchers said on Saturday.

Vector immunity is not a new issue but has come under renewed scrutiny as companies including Johnson & Johnson anticipate regular COVID-19 vaccinations, like annual influenza shots, may be needed to combat new variants of the coronavirus.

owais.usmani wrote:https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-approved-for-use-in-angola-congo-and-djibouti/

SPUTNIK V APPROVED FOR USE IN ANGOLA, CONGO AND DJIBOUTI

Starting to conquer Africa as well.

calripson wrote:

owais.usmani wrote:https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-approved-for-use-in-angola-congo-and-djibouti/

SPUTNIK V APPROVED FOR USE IN ANGOLA, CONGO AND DJIBOUTI

Starting to conquer Africa as well.

Russians have a habit of being too charitable. Make everyone pay - full price.

It's just that vaccine is so straightforward and simple to make that full price is not too high

GarryB wrote:They can pay later when it comes time to trade.... remember that time we helped you guys out.... we are the nice guys....

It's just that vaccine is so straightforward and simple to make that full price is not too high

It might also be that they are able to produce it themselves which means expanded production base which is good for Russia as well.

GarryB wrote:They can pay later when it comes time to trade.... remember that time we helped you guys out.... we are the nice guys....

Sputnik V could bring Russia hundreds of billions of dollars
...
https://zen.yandex.ru/media/octagon_media/sputnik-v-mojet-prinesti-rossii-sotni-milliardov-dollarov-60369c7f109f4c102e1b04c3

owais.usmani wrote:EU approval of sputnik V is getting closer

https://www.ema.europa.eu/en/news/ema-starts-rolling-review-sputnik-v-covid-19-vaccine

EMA’s human medicines committee (CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine1 developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology. The EU applicant for this medicine is R-Pharm Germany GmbH.

The CHMP’s decision to start the rolling review is based on results from laboratory studies and clinical studies in adults. These studies indicate that Sputnik V triggers the production of antibodies and immune cells that target the SARS-CoV-2 coronavirus and may help protect against COVID-19.

EMA will evaluate data as they become available to decide if the benefits outweigh the risks. The rolling review will continue until enough evidence is available for formal marketing authorisation application.

EMA will assess Sputnik V’s compliance with the usual EU standards for effectiveness, safety and quality. While EMA cannot predict the overall timelines, it should take less time than normal to evaluate an eventual application because of the work done during the rolling review.

EMA will communicate further when the marketing authorisation application for the vaccine has been submitted.

LMFS wrote:

owais.usmani wrote:EU approval of sputnik V is getting closer

https://www.ema.europa.eu/en/news/ema-starts-rolling-review-sputnik-v-covid-19-vaccine

EMA’s human medicines committee (CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine1 developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology. The EU applicant for this medicine is R-Pharm Germany GmbH.

The CHMP’s decision to start the rolling review is based on results from laboratory studies and clinical studies in adults. These studies indicate that Sputnik V triggers the production of antibodies and immune cells that target the SARS-CoV-2 coronavirus and may help protect against COVID-19.

EMA will evaluate data as they become available to decide if the benefits outweigh the risks. The rolling review will continue until enough evidence is available for formal marketing authorisation application.

EMA will assess Sputnik V’s compliance with the usual EU standards for effectiveness, safety and quality. While EMA cannot predict the overall timelines, it should take less time than normal to evaluate an eventual application because of the work done during the rolling review.

EMA will communicate further when the marketing authorisation application for the vaccine has been submitted.

The CHIMPS is a wonderful name for that bunch of clowns, hail to the one that came up with it

"May" help against COVID? To decide if the benefits outweigh the risks? The guys that granted immunity to unscrupulous manufacturers experimenting with the general population??? Compliance with the usual EU standards??? Will they need to bribe them too?

Really these clowns are too much for any sane person....

In fact, they're criminal chimps playing deadly geopolitical games with the health and ultimately risking lives with the European population.